Baxter International Inc.’s stock price takes a hit, plunging to $34.51 – a steep 6.55% drop

Baxter International Inc. (BAX)

34.51 USD -2.42 (-6.55%) Volume: 9.72M

Baxter International Inc.’s stock price stands at 34.51 USD, witnessing a decline of -6.55% this trading session with a trading volume of 9.72M, reflecting a year-to-date percentage change of -10.73%, underlining the need for strategic investment decisions.

Latest developments on Baxter International Inc.

Baxter International made headlines today as it announced the sale of its kidney care business, Vantive, to investment firm Carlyle Group for a staggering $3.8 billion. This strategic shift towards divesting its renal care unit caused Baxter’s stock price to slide by 6.5%. The deal, which is set to be finalized soon, marks a significant move for the healthcare company. With this acquisition, Carlyle is set to take over Baxter’s kidney care arm, further solidifying its position in the healthcare industry. This news comes amidst other recent developments, including Baxter’s notification of a data breach in June 2024 and its successful Q2 earnings report, beating revenue estimates. Analysts have also raised Baxter International‘s share price target to $42.15, indicating a 13.5% upside potential for investors.

Baxter International Inc. on Smartkarma

Baxter International has received positive analyst coverage on Smartkarma from Baptista Research. According to their research report titled “Baxter International: Driving Revenue with New Innovations and Competitive Conversions! – Major Drivers,” the company exceeded its first quarter 2024 earnings guidance with 2% growth on a reported basis and 3% at constant currency rates. This performance was attributed to strong demand and favorable pricing for a wide range of Baxter’s products, showcasing the benefits of the company’s strategic transformation.

A look at Baxter International Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Baxter International has a strong outlook for its dividend and momentum. The company received a high score of 5 for its dividend, indicating that it is a reliable choice for investors looking for steady income. Additionally, Baxter International scored a 4 for momentum, suggesting that the company is experiencing positive growth and market traction. However, the company scored lower in terms of value, growth, and resilience, indicating that there may be some areas for improvement in the long term.

Baxter International Inc. is a company that focuses on developing and marketing products related to various medical conditions. With a strong emphasis on hemophilia, immune disorders, kidney disease, and more, Baxter International serves a wide range of healthcare facilities and professionals. While the company’s dividend and momentum scores are promising, investors may want to keep an eye on factors such as growth and resilience to assess the company’s long-term performance and stability in the market.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma